ADVERTISEMENT
ADVERTISEMENT

Dr Reddy's launches skin treatment drug in US

Dr Reddy
Highlights

Dr Reddy's Laboratories on Wednesday said it launched Daptomycin for injection, used for treating complicated skin infections, in the US market.

New Delhi: Dr Reddy's Laboratories on Wednesday said it launched Daptomycin for injection, used for treating complicated skin infections, in the US market.

The company launched its product, which is generic version of Merck Sharp & Dohme Corp's Cubicin, after obtaining approval from the US Food and Drug Administration (USFDA), the pharma major said.

According to IQVIA Health, the Cubicin for injection (daptomycin for injection) brand and generics had sales of around $640.8 million for the most recent 12 months ending in March 2019.

Show Full Article
Download The Hans India Android App or iOS App for the Latest update on your phone.
Subscribed Failed...
Subscribed Successfully...
More Stories


Top